Human NK cell education by inhibitory receptors for MHC class I.

[1]  R. Vance,et al.  Self-tolerance of natural killer cells , 2006, Nature Reviews Immunology.

[2]  P. Parham,et al.  Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function , 2006, The Journal of experimental medicine.

[3]  W. Yokoyama,et al.  How do natural killer cells find self to achieve tolerance? , 2006, Immunity.

[4]  D. F. Barber,et al.  Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells , 2005, The Journal of experimental medicine.

[5]  Eric Vivier,et al.  Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[6]  L. Lybarger,et al.  Licensing of natural killer cells by host major histocompatibility complex class I molecules , 2005, Nature.

[7]  R. Vance,et al.  A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. , 2005, Blood.

[8]  P. Parham.  MHC class I molecules and kirs in human history, health and survival , 2005, Nature Reviews Immunology.

[9]  Antonio Lanzavecchia,et al.  Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming , 2004, Nature Immunology.

[10]  Eric Vivier,et al.  Natural Killer Cell Signaling Pathways , 2004, Science.

[11]  A. Oxenius,et al.  Immediate Cytotoxicity But Not Degranulation Distinguishes Effector and Memory Subsets of CD8+ T Cells , 2004, The Journal of experimental medicine.

[12]  C. Münz,et al.  NK Cell Compartments and Their Activation by Dendritic Cells1 , 2004, The Journal of Immunology.

[13]  L. Moretta,et al.  Unravelling natural killer cell function: triggering and inhibitory human NK receptors , 2004, The EMBO journal.

[14]  Mario Roederer,et al.  Ex vivo identification, isolation and analysis of tumor-cytolytic T cells , 2003, Nature Medicine.

[15]  B. Plougastel,et al.  Immune functions encoded by the natural killer gene complex , 2003, Nature Reviews Immunology.

[16]  D. Middleton,et al.  Molecular diversity of the HLA-C gene identified in a caucasian population. , 2002, Human immunology.

[17]  P. Sun,et al.  A structural perspective on MHC class I recognition by killer cell immunoglobulin-like receptors. , 2002, Molecular immunology.

[18]  Katia Perruccio,et al.  Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants , 2002, Science.

[19]  J. Zimmer,et al.  Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells. , 2002, Blood.

[20]  J. Trowsdale,et al.  Genetic and functional relationships between MHC and NK receptor genes. , 2001, Immunity.

[21]  M. Caligiuri,et al.  Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset , 2001 .

[22]  L. Lanier,et al.  Immune inhibitory receptors. , 2000, Science.

[23]  D Middleton,et al.  Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires. , 2000, Tissue antigens.

[24]  J. Ortaldo,et al.  Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice. , 2000, Immunity.

[25]  B. Blom,et al.  DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. , 2000, Immunity.

[26]  P. Anderson,et al.  Modification of P-selectin glycoprotein ligand-1 with a natural killer cell-restricted sulfated lactosamine creates an alternate ligand for L-selectin. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Fischer,et al.  Natural and engineered disorders of lymphocyte development. , 1998, Science.

[28]  J. Zimmer,et al.  Activity and Phenotype of Natural Killer Cells in Peptide Transporter (TAP)-deficient Patients (Type I Bare Lymphocyte Syndrome) , 1998, The Journal of experimental medicine.

[29]  P Parham,et al.  Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. , 1997, Immunity.

[30]  H. Ljunggren,et al.  Host MHC class I gene control of NK‐cell specificity in the mouse , 1997, Immunological reviews.

[31]  J. Dorfman,et al.  Major histocompatibility complex genes determine natural killer cell tolerance , 1996, European journal of immunology.

[32]  K. Kärre,et al.  Altered phenotype and function of natural killer cells expressing the major histocompatibility complex receptor Ly-49 in mice transgenic for its ligand. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[33]  R. Welsh,et al.  NK cell response to viral infections in beta 2-microglobulin-deficient mice. , 1995, Journal of immunology.

[34]  M. Carrington,et al.  The impact of variation at the KIR gene cluster on human disease. , 2006, Current topics in microbiology and immunology.

[35]  D. Margulies,et al.  Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination. , 2002, Annual review of immunology.

[36]  R. Biassoni,et al.  What is a natural killer cell? , 2002, Nature Immunology.

[37]  R. Vance,et al.  Regulation of the natural killer cell receptor repertoire. , 2001, Annual review of immunology.

[38]  K. Tadokoro,et al.  Tolerance of NK and LAK activity for HLA class I-deficient targets in a TAP1-deficient patient (bare lymphocyte syndrome type I). , 1999, Human immunology.

[39]  É. Vivier,et al.  Biology of immunoreceptor tyrosine-based inhibition motif-bearing molecules. , 1999, Current topics in microbiology and immunology.

[40]  Eric O Long,et al.  Regulation of immune responses through inhibitory receptors. , 1999, Annual review of immunology.

[41]  H. Ljunggren,et al.  In search of the 'missing self': MHC molecules and NK cell recognition. , 1990, Immunology today.